A respiratory virus nucleic acid detection kit (isothermal amplification method) that can detect six types of respiratory viruses including the novel coronavirus (2019-nCoV) at one time within 1.5 hours was approved by China’s National Medical Products Administration on Feb 22 to be used clinically as a novel coronavirus emergency medical device.
An increasing number of enterprises under Tsinghua Holdings are participating in the national battle against COVID-19.
Many subsidiaries under Tsinghua Holdings are giving technologies and services as part of their ongoing support of the national efforts in prevention and control of the novel coronavirus pneumonia (COVID-19).
High-tech companies under Tsinghua Holdings have provided services and products to help combat the outbreak of novel coronavirus (COVID-19) in Wuhan city, Central China’s Hubei province.
Subsidiaries of Tsinghua Holdings, including Tus-Holdings, Chengzhi Holdings, MOOC-EN Education, and Beijing GS Technology Co Ltd (GSAFETY), have shouldered their social responsibility and taken active and effective actions to combat the novel coronavirus pneumonia (NCP), which the WHO refers to as COVID-19.
Subsidiary companies of Tsinghua Holdings, including Tus-Holdings, Chengzhi Holdings, Tsinghua University Press, and MOOC-CN Education, give full play to their advantages and work hard to fight against the novel coronavirus pneumonia (NCP), which the WHO has named COVID-19.